Literature DB >> 16821713

Occurrence of aminoglycoside-modifying-enzyme genes aac(6')-aph(2"), aph(3'), ant(4') and ant(6) in clinical isolates of Enterococcus faecalis resistant to high-level of gentamicin and amikacin.

M Filipová1, H Bujdákova, H Drahovská, A Lisková, J Hanzen.   

Abstract

The genes coding for 4 aminoglycoside-modifying enzymes AAC(6')-APH(2"), APH(3'), ANT(4') and ANT(6) were determined in 44 Slovak clinical isolates of Enterococcus faecalis with high-level resistance to gentamicin (HLGR, collection 1) and 48 E. faecalis isolates with resistance to amikacin (AR, collection 2). The occurrence of spotted genes was (collection 1 vs. collection 2): aac(6)-aph(2") 81.8 vs. 8.3 %, ant(4') 52.3 vs. 81.3 %, aph(3') 50 vs. 56.3 % and ant(6) 6.8 vs. 4.2 %, the most frequent combinations of genes in the HLGR collection were aac(6')-aph(2") + ant(4') and aac(6')-aph(2") + aph(3). In contrast, the aph(3') + ant(4') gene profile was predominant in AR isolates. None of the isolates contained all four AGME genes simultaneously.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821713     DOI: 10.1007/BF02931451

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  21 in total

1.  Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters.

Authors:  F M E Wagenlehner; S Krcmery; C Held; I Klare; W Witte; A Bauernfeind; I Schneider; K G Naber
Journal:  Int J Antimicrob Agents       Date:  2002-06       Impact factor: 5.283

2.  Detection of a novel aph(2") allele (aph[2"]-Ie) conferring high-level gentamicin resistance and a spectinomycin resistance gene ant(9)-Ia (aad 9) in clinical isolates of enterococci.

Authors:  Mohammed Mahbub Alam; Nobumichi Kobayashi; Masaho Ishino; Ayako Sumi; Ken-Ichiro Kobayashi; Nobuyuki Uehara; Naoki Watanabe
Journal:  Microb Drug Resist       Date:  2005       Impact factor: 3.431

3.  Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities.

Authors:  J J Ferretti; K S Gilmore; P Courvalin
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

4.  Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food.

Authors:  S M Donabedian; L A Thal; E Hershberger; M B Perri; J W Chow; P Bartlett; R Jones; K Joyce; S Rossiter; K Gay; J Johnson; C Mackinson; E Debess; J Madden; F Angulo; M J Zervos
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 5.  Aminoglycoside resistance in enterococci.

Authors:  J W Chow
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

6.  Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain.

Authors:  R del Campo; C Tenorio; C Rubio; J Castillo; C Torres; R Gómez-Lus
Journal:  Int J Antimicrob Agents       Date:  2000-08       Impact factor: 5.283

7.  Antibiotic resistance among enterococcal strains isolated from clinical specimens.

Authors:  Z Barisić; V Punda-Polić
Journal:  Int J Antimicrob Agents       Date:  2000-09       Impact factor: 5.283

8.  Colonization by high-level aminoglycoside-resistant enterococci in intensive care unit patients: epidemiology and clinical relevance.

Authors:  J Rodríguez-Baño; E Ramírez; M A Muniain; J Santos; P Joyanes; F González; M García-Sánchez; L Martínez-Martínez
Journal:  J Hosp Infect       Date:  2005-08       Impact factor: 3.926

9.  Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999.

Authors:  John Turnidge; Jan Bell; Douglas J Biedenbach; Ronald N Jones
Journal:  Int J Antimicrob Agents       Date:  2002-07       Impact factor: 5.283

10.  Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002.

Authors:  James A Karlowsky; Mark E Jones; Deborah C Draghi; Clyde Thornsberry; Daniel F Sahm; Gregory A Volturo
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-05-10       Impact factor: 3.944

View more
  3 in total

1.  High Incidence of Virulence Factors Among Clinical Enterococcus faecalis Isolates in Southwestern Iran.

Authors:  Hamid Heidari; Somayeh Hasanpour; Hadi Sedigh Ebrahim-Saraie; Mohammad Motamedifar
Journal:  Infect Chemother       Date:  2017-03-13

2.  Antimicrobial susceptibility of Enterococcus species isolated from Slovak Bryndza cheese.

Authors:  A Belicová; L Krzková; J Krajcovic; D Jurkovic; M Sojka; L Ebringer; R Duinský
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

3.  Properties of the strains Enterococcus haemoperoxidus and E. moraviensis, new species among enterococci.

Authors:  A Lauková; P Svec; V Strompfová; V Stĕtina; I Sedlácek
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.